L712-0741 Screening compound: N-(4-bromo-2-fluorophenyl)-4-{2-[2-(propan-2-yl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide

L712-0741 Screening compound: N-(4-bromo-2-fluorophenyl)-4-{2-[2-(propan-2-yl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide
L712-0741 Screening compound: N-(4-bromo-2-fluorophenyl)-4-{2-[2-(propan-2-yl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L712-0741
N-(4-bromo-2-fluorophenyl)-4-{2-[2-(propan-2-yl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L712-0741

Molecular Formula

C22H26BrFN6O (C22 H26 BrFN6 O)

Compound Name

N-(4-bromo-2-fluorophenyl)-4-{2-[2-(propan-2-yl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide

IUPAC name

N-(4-bromo-2-fluorophenyl)-4-{2-[2-(propan-2-yl)-3H-imidazo[45-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide

SMILES

CC(C)c1nc2cccnc2n1CCN(CC1)CCN1C(Nc(ccc(Br)c1)c1F)=O

InChI

InChI=1S/C22H26BrFN6O/c1-15(2)20-26-19-4-3-7-25-21(19)30(20)13-10-28-8-11-29(12-9-28)22(31)27-18-6-5-16(23)14-17(18)24/h3-7,14-15H,8-13H2,1-2H3,(H,27,31)

InChI Key

AHHVOQANPHXVKL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15133713

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

489.39

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.961

Distribution Coefficient, logD

3.925

Water Solubility, LogSw

-3.89

Polar Surface Area

48.614

Acid Dissociation Constant (pKa)

10.34

Base Dissociation Constant (pKb)

6.33

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.90

L712-0741 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Cardiovascular
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L712-0741 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L712-0741?
Check Price and Availability of L712-0741, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L712-0741 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L712-0741
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L712-0741
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L712-0741 available by request